» Articles » PMID: 11735101

Are There Persons Who Are Obese, but Metabolically Healthy?

Overview
Journal Metabolism
Specialty Endocrinology
Date 2001 Dec 6
PMID 11735101
Citations 175
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this article was to review the evidence for a metabolically normal subset of the obese and its implications for clinical and research work. The methods included literature review and correspondence with authors. Since 1947, when Vague described a relation between distribution of body fat and the risk factors for cardiovascular disease, much evidence has suggested that early onset of the obesity, hyperplasia of normal adipocytes, and normal quantities of visceral abdominal fat may be associated with a favorable metabolic response in obese subjects. Analyses in 1973 by Keyes and later by Reuben Andres in 1980 suggested that obesity for some was not a risk factor and might even be an asset. Recently, in the study by Bonora et al of the relation between insulin resistance and the 4 main disorders of the metabolic syndrome in the Bruneck epidemiologic study, a subgroup of obese individuals with a normal metabolic response was evident. In a current study by Brochu et al of an obese metabolically normal subgroup of postmenopausal women, visceral abdominal fat estimated by computed tomography (CT) scan and age of onset were significant variables. The obese, metabolically normal subgroup (OBMN) must be taken into consideration in both clinical and research work. Persons with OBMN and their parents may be wrongly blamed because of the obesity. Attempts at weight loss may be counterproductive. The criteria for selection of obese research subjects may favor inclusion of an OBMN subset, which may invalidate statistical analysis. Findings suggesting the OBMN subset include family members with uncomplicated obesity, early onset of the obesity, fasting plasma insulin within normal range, and normal distribution of the excess fat. Hormonal, genetic studies, and prospective studies will help to clarify the significance and underlying mechanisms of this subset.

Citing Articles

Multi-omics architecture of childhood obesity and metabolic dysfunction uncovers biological pathways and prenatal determinants.

Stratakis N, Anguita-Ruiz A, Fabbri L, Maitre L, Gonzalez J, Andrusaityte S Nat Commun. 2025; 16(1):654.

PMID: 39809770 PMC: 11732992. DOI: 10.1038/s41467-025-56013-7.


Relationship between Body Adiposity Indices and Reversal of Metabolically Unhealthy Obesity 6 Months after Roux-en-Y Gastric Bypass.

Luna M, Pereira S, Saboya C, Ramalho A Metabolites. 2024; 14(9).

PMID: 39330509 PMC: 11434138. DOI: 10.3390/metabo14090502.


Relationship of Mitochondrial DNA Oxidation and Content with Metabolic Syndrome and Cardiovascular Risk in Obesity Phenotypes.

Rojo M, Perez H, Millan A, Pautasso M, Frechtel G, Cerrone G J Obes. 2024; 2024:3008093.

PMID: 39297082 PMC: 11410407. DOI: 10.1155/2024/3008093.


Genetic determinants of obesity in Korean populations: exploring genome-wide associations and polygenic risk scores.

Jo J, Ha N, Ji Y, Do A, Seo J, Oh B Brief Bioinform. 2024; 25(5).

PMID: 39207728 PMC: 11359806. DOI: 10.1093/bib/bbae389.


Association between metabolic obesity phenotypes and the risk of developing prostate cancer: a propensity score matching study based on Xinjiang.

Wang J, Apizi A, Qiu H, Tao N, An H Front Endocrinol (Lausanne). 2024; 15:1442740.

PMID: 39165513 PMC: 11333236. DOI: 10.3389/fendo.2024.1442740.